The longitudinal investigation on 16 anti‐CRT Ab‐positive IIM patients, including 3 IIM–cancer patients, demonstrated that the variations in anti‐CRT Ab levels positively correlated with the changes in MYOACT scores during the follow‐up visits. This evidence concerns the gene CALR and cancer.